You are here: Industry Insights > Pfizer

News List

New advice issued on COVID-19 vaccination of children and young people pharmatimes
July 21, 2021
The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has advised that children with an increased risk of serious illness from COVID-19 should be offered the Pfizer/BioNTech vaccine.
Pfizer Expands its Voluntary Recall of Chantix americanpharmaceuticalreview
July 21, 2021
Pfizer expanded its voluntary recall of varenicline (Chantix) to 12 consumer-level lots. Pfizer is recalling these lots due to the presence of N-nitroso-varenicline above the company’s acceptable limit for this impurity.
Covid-19: At-risk children to be offered Pfizer/BioNTech vaccine firstwordpharma
July 20, 2021
UK health secretary Sajid Javid said children who are at increased risk of COVID-19 will be offered Pfizer/BioNTech's vaccine on the NHS "as soon as possible," as are those who are immunocompromised, as reported in This is Money.
Pfizer-BioNTech’s Covid-19 vaccine receives FDA priority review pharmaceutical-technology
July 19, 2021
The US Food and Drug Administration (FDA) has granted priority review designation to biologics license application (BLA) submitted by Pfizer and BioNTech for their Covid-19 vaccine.
FDA to Prioritize Full Approval for Pfizer COVID-19 Vaccine drugs
July 19, 2021
Pfizer Inc. announced on Friday that the U.S. Food and Drug Administration has granted priority review to its COVID-19 vaccine, positioning the vaccine for full approval by January.
Collaboration between AbbVie, Biogen and Pfizer creates world's largest browsable resource linking rare protein-coding genetic variants to human health and disease worldpharmanews
July 16, 2021
The access to the world's largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequence analysis collaboration between AbbVie, Biogen Inc. and Pfizer.
Report finds almost 100% of people tested positive for antibodies after second vaccine dose pharmatimes
July 16, 2021
A new report from Imperial College London and Ipsos MORI has shown that almost 100% of people tested positive for antibodies 14 days after their second dose of the Pfizer/BioNTech or AstraZeneca COVID-19 vaccines.
Almost 100% of people have antibodies after second vaccine firstwordpharma
July 16, 2021
Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, almost 100% of people tested positive for antibodies 14 days after their second dose of the Pfizer and AstraZeneca vaccine.
Delivery of Pfizer jabs to be cut 10% in Osaka, Tokyo’s Setagaya, more firstwordpharma
July 15, 2021
Japan’s government will reduce the supply of Pfizer’s COVID-19 vaccine to local governments by 10% for the first half of August if they are deemed to have an excess stock of it, The Asahi Shimbun reported.
Pfizer Presses U.S. Scientists, Officials on Third Booster Shot drugs
July 14, 2021
Pfizer made its case for quick U.S. approval of a third booster shot of its COVID-19 vaccine during a meeting with the country's top scientists and federal regulators on Monday.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page